busulfan has been researched along with Syndrome in 18 studies
Syndrome: A characteristic symptom complex.
| Excerpt | Relevance | Reference |
|---|---|---|
| " From 1974 to 1986 we treated 20 symptomatic ET patients with microvascular circulation disturbances including erythromelalgia (N = 18), atypical or typical transient ischemic attacks (N = 6), or acute coronary ischemic syndrome (N = 3) with aspirin and one course of busulfan." | 9.09 | Normal life expectancy and thrombosis-free survival in aspirin treated essential thrombocythemia. ( Michiels, JJ, 1999) |
| "Over a 19-year period, a patient with polycythemia vera who had undergone a splenectomy received six courses of busulfan for recurrent thrombocytosis." | 7.65 | Erythroleukemia-like syndrome due to busulfan toxicity in polycythemia vera. ( Kim, HC; Lindenbaum, J; Pezzimenti, JF, 1976) |
| " From 1974 to 1986 we treated 20 symptomatic ET patients with microvascular circulation disturbances including erythromelalgia (N = 18), atypical or typical transient ischemic attacks (N = 6), or acute coronary ischemic syndrome (N = 3) with aspirin and one course of busulfan." | 5.09 | Normal life expectancy and thrombosis-free survival in aspirin treated essential thrombocythemia. ( Michiels, JJ, 1999) |
| "Over a 19-year period, a patient with polycythemia vera who had undergone a splenectomy received six courses of busulfan for recurrent thrombocytosis." | 3.65 | Erythroleukemia-like syndrome due to busulfan toxicity in polycythemia vera. ( Kim, HC; Lindenbaum, J; Pezzimenti, JF, 1976) |
| " In the (T)BU/CY patients only, the association of the pharmacokinetic data with liver toxicity, relapse, and survival was evaluated." | 2.73 | Cyclophosphamide following targeted oral busulfan as conditioning for hematopoietic cell transplantation: pharmacokinetics, liver toxicity, and mortality. ( Batchelder, A; Cole, S; Deeg, HJ; Gooley, T; McCune, JS; McDonald, GB; Phillips, B; Schoch, HG, 2007) |
| "The syndrome was characterised by sudden onset of circulatory shock and cardiac arrest." | 1.28 | Sudden cardiac tamponade after chemotherapy for marrow transplantation in thalassaemia. ( Angelucci, E; Baronciani, D; Cesaroni, P; Durazzi, SM; Galimberti, M; Giardini, C; Lucarelli, G; Mariotti, E; Muretto, P; Polchi, P, 1992) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 11 (61.11) | 18.7374 |
| 1990's | 4 (22.22) | 18.2507 |
| 2000's | 3 (16.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| KYLE, RA | 1 |
| SCHWARTZ, RS | 1 |
| OLINER, HL | 1 |
| DAMESHEK, W | 1 |
| Chen, J | 1 |
| Sauer, M | 1 |
| Zeidler, C | 1 |
| Meissner, B | 1 |
| Rehe, K | 1 |
| Hanke, A | 1 |
| Welte, K | 1 |
| Lohse, P | 1 |
| Sykora, KW | 1 |
| McCune, JS | 1 |
| Batchelder, A | 1 |
| Deeg, HJ | 1 |
| Gooley, T | 1 |
| Cole, S | 1 |
| Phillips, B | 1 |
| Schoch, HG | 1 |
| McDonald, GB | 1 |
| Flaum, MA | 1 |
| Schooley, RT | 1 |
| Fauci, AS | 1 |
| Gralnick, HR | 1 |
| Gomez, L | 1 |
| Le Deist, F | 1 |
| Blanche, S | 1 |
| Cavazzana-Calvo, M | 1 |
| Griscelli, C | 1 |
| Fischer, A | 1 |
| Tutschka, PJ | 1 |
| Michiels, JJ | 1 |
| Wohl, MA | 1 |
| Wood, JK | 1 |
| Spiers, AS | 1 |
| Morley, AA | 1 |
| Trainor, KJ | 1 |
| Seshadri, RS | 1 |
| Solley, GO | 1 |
| Maldonado, JE | 1 |
| Gleich, GJ | 1 |
| Giuliani, ER | 1 |
| Hoagland, HC | 1 |
| Pierre, RV | 1 |
| Brown, AL | 1 |
| Pezzimenti, JF | 1 |
| Kim, HC | 1 |
| Lindenbaum, J | 1 |
| Rose, MS | 1 |
| Angelucci, E | 1 |
| Mariotti, E | 1 |
| Lucarelli, G | 1 |
| Baronciani, D | 1 |
| Cesaroni, P | 1 |
| Durazzi, SM | 1 |
| Galimberti, M | 1 |
| Giardini, C | 1 |
| Muretto, P | 1 |
| Polchi, P | 1 |
| Resnick, M | 1 |
| Myerson, RM | 1 |
| Aust, C | 1 |
| Boll, I | 1 |
| Pinto-Machado, J | 1 |
2 reviews available for busulfan and Syndrome
| Article | Year |
|---|---|
Animal models for acquired bone marrow failure syndromes.
Topics: Anemia, Aplastic; Animals; Benzene; Bone Marrow Diseases; Busulfan; Chloramphenicol; Disease Models, | 2005 |
Use of busulfan containing chemotherapy for conditioning patients with leukemia for bone marrow allografting.
Topics: Actuarial Analysis; Adult; Bone Marrow Purging; Bone Marrow Transplantation; Busulfan; Cyclophospham | 1993 |
3 trials available for busulfan and Syndrome
| Article | Year |
|---|---|
Substitution of cyclophosphamide and busulfan by fludarabine, treosulfan and melphalan in a preparative regimen for children and adolescents with Shwachman-Diamond syndrome.
Topics: Abnormalities, Multiple; Adolescent; Bone Marrow Diseases; Busulfan; Child; Child, Preschool; Cyclop | 2007 |
Cyclophosphamide following targeted oral busulfan as conditioning for hematopoietic cell transplantation: pharmacokinetics, liver toxicity, and mortality.
Topics: Administration, Oral; Adolescent; Adult; Aged; Busulfan; Chemical and Drug Induced Liver Injury; Cyc | 2007 |
Normal life expectancy and thrombosis-free survival in aspirin treated essential thrombocythemia.
Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Aspirin; Busulfan; Coronary Disease; Dise | 1999 |
13 other studies available for busulfan and Syndrome
| Article | Year |
|---|---|
A syndrome resembling adrenal cortical insufficiency associated with long term busulfan (myleran) therapy.
Topics: Adrenal Cortex; Adrenal Cortex Diseases; Busulfan; Humans; Syndrome | 1961 |
A clinicopathologic correlation of the idiopathic hypereosinophilic syndrome. I. Hematologic manifestations.
Topics: Bone Marrow; Busulfan; Cyclophosphamide; Dose-Response Relationship, Drug; Eosinophilia; Eosinophils | 1981 |
Treatment of Omenn syndrome by bone marrow transplantation.
Topics: Bone Marrow Transplantation; Busulfan; Child; Child, Preschool; Cyclophosphamide; Female; Graft Reje | 1995 |
Chronic myeloid leukaemia and a myasthenic syndrome.
Topics: Adult; Bone Marrow; Bronchial Neoplasms; Busulfan; Carcinoma; Humans; Leukemia, Myeloid; Male; Muscu | 1979 |
The clinical features of chronic granulocytic leukaemia.
Topics: Adult; Busulfan; Cell Transformation, Neoplastic; Female; Humans; Leukemia, Myeloid; Male; Middle Ag | 1977 |
Chronic hypoplastic marrow failure and residual injury.
Topics: Anemia, Aplastic; Animals; Bone Marrow; Bone Marrow Transplantation; Busulfan; Cell Division; Chroni | 1978 |
Endomyocardiopathy with eosinophilia.
Topics: Adolescent; Adult; Busulfan; Cardiomyopathies; Cytoplasmic Granules; Digoxin; Diphenhydramine; Eosin | 1976 |
Erythroleukemia-like syndrome due to busulfan toxicity in polycythemia vera.
Topics: Adult; Bone Marrow; Bone Marrow Diseases; Busulfan; Female; Humans; Leukemia, Erythroblastic, Acute; | 1976 |
Busulphan toxicity syndrome caused by chlorambucil.
Topics: Aged; Busulfan; Chlorambucil; Female; Humans; Leukemia, Lymphoid; Male; Middle Aged; Pigmentation Di | 1975 |
Sudden cardiac tamponade after chemotherapy for marrow transplantation in thalassaemia.
Topics: Acute Disease; Adolescent; Bone Marrow Transplantation; Busulfan; Cardiac Tamponade; Child; Child, P | 1992 |
Hypereosinophilic syndrome. Report of two cases, with prolonged courses.
Topics: Adult; Busulfan; Cardiomegaly; Chronic Disease; Cyclophosphamide; Eosinophilia; Eosinophils; Hepatom | 1971 |
[Development of Di-Gugliemo syndromes from chronic myelocytic leukemias].
Topics: Adult; Aged; Bone Marrow Cells; Bone Marrow Examination; Busulfan; Cell Transformation, Neoplastic; | 1974 |
Influence of prenatal administration of busulfan on the postnatal development of mice. Production of a syndrome including hypoplasia of the thymus.
Topics: Abnormalities, Drug-Induced; Abnormalities, Multiple; Animals; Bone Development; Busulfan; Female; F | 1970 |